Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 25;13(11):2146.
doi: 10.3390/v13112146.

Respiratory Viruses in Solid Organ Transplant Recipients

Roni Bitterman  1 , Deepali Kumar  1
Affiliations
Review

Respiratory Viruses in Solid Organ Transplant Recipients

Roni Bitterman et al. Viruses. .

Abstract

Solid organ transplantation is often lifesaving, but does carry an increased risk of infection. Respiratory viral infections are one of the most prevalent infections, and are a cause of significant morbidity and mortality, especially among lung transplant recipients. There is also data to suggest an association with acute rejection and chronic lung allograft dysfunction in lung transplant recipients. Respiratory viral infections can appear at any time post-transplant and are usually acquired in the community. All respiratory viral infections share similar clinical manifestations and are all currently diagnosed using nucleic acid testing. Influenza has good treatment options and prevention strategies, although these are hampered by resistance to neuraminidase inhibitors and lower vaccine immunogenicity in the transplant population. Other respiratory viruses, unfortunately, have limited treatments and preventive methods. This review summarizes the epidemiology, clinical manifestations, therapies and preventive measures for clinically significant RNA and DNA respiratory viruses, with the exception of SARS-CoV-2. This area is fast evolving and hopefully the coming decades will bring us new antivirals, immunologic treatments and vaccines.

Keywords: RSV; coronavirus; influenza; lung transplant; metapneumovirus; parainfluenza; prevention; vaccine.

PubMed Disclaimer

Conflict of interest statement

D.K. has received research grants from Roche and GSK, advisory fees from Roche, GSK, Astellas, Sanofi.

Similar articles

See all similar articles

References

    1. Bridevaux P.O., Aubert J.D., Soccal P.M., Mazza-Stalder J., Berutto C., Rochat T., Turin L., Van Belle S., Nicod L., Meylan P., et al. Incidence and outcomes of respiratory viral infections in lung transplant recipients: A prospective study. Thorax. 2014;69:32–38. doi: 10.1136/thoraxjnl-2013-203581. - DOI - PubMed
    1. Peghin M., Hirsch H.H., Len Ó., Codina G., Berastegui C., Sáez B., Solé J., Cabral E., Solé A., Zurbano F., et al. Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study. Am. J. Transplant. 2017;17:1304–1312. doi: 10.1111/ajt.14042. - DOI - PMC - PubMed
    1. López-Medrano F., Aguado J.M., Lizasoain M., Folgueira D., Juan R.S., Díaz-Pedroche C., Lumbreras C., Morales J.M., Delgado J.F., Moreno-González E. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study. Transplantation. 2007;84:851–856. doi: 10.1097/01.tp.0000282788.70383.8b. - DOI - PubMed
    1. Law N., Kumar D. Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs Aging. 2017;34:743–754. doi: 10.1007/s40266-017-0491-5. - DOI - PMC - PubMed
    1. Ruuskanen O., Lahti E., Jennings L.C., Murdoch D.R. Viral pneumonia. Lancet. 2011;377:1264–1275. doi: 10.1016/S0140-6736(10)61459-6. - DOI - PMC - PubMed

MeSH terms

Substances